The effect of unfractionated heparin on thrombelastographic analysis in healthy dogs
- 1 April 2010
- journal article
- research article
- Published by Wiley in Journal of Veterinary Emergency and Critical Care
- Vol. 20 (2) , 216-223
Abstract
To determine the effect of single and multiple doses of SQ heparin (200 U/kg) on the thrombelastogram of healthy dogs. Prospective study. University research facility. Six random-source female dogs. Baseline parameters, including a CBC with platelet count, prothrombin time, activated partial thromboplastin time (aPTT), and antithrombin were performed. Thrombelastography (TEG) and aPTT were performed hourly for 12 hours after unfractionated heparin dosing (200 U/kg, SQ). Anti-Xa activity was assayed at 0, 3, 6, and 8 hours. Heparin was then administered every 8 hours for 3 days. The sampling protocol on Day 4 was identical to Day 1. On Day 1, percentage change from baseline for TEG parameter R, as well as absolute values of K, angle, and maximum amplitude (MA) were evaluated. Statistically significant (P<0.01) prolongation of the R time and a decrease in angle and MA was seen in all dogs by hour 3. R and MA were unmeasurable for most dogs between 3 and 5 hours. All TEG tracings returned to baseline by 12 hours. Day 4 TEG tracings mimicked those on Day 1. Only 1 dog achieved aPTT values outside the reference interval on both days. Anti-Xa activity levels increased on Day 4 but not on Day 1. Based on post hoc in vitro analysis, prolongation of R time occurred at plasma heparin levels as low as 0.075 U/mL, well below the lower limit of detection of the anti-Xa activity level assay. Administration of SQ heparin results in progressive changes in the TEG tracing, with maximal change occurring 3-5 hours after dosing. The extensive prolongation of the R time also indicates that TEG may be too sensitive and limits its utility as a monitoring tool for unfractionated heparin therapy.Keywords
This publication has 22 references indexed in Scilit:
- Thrombelastography in 26 healthy horses with and without activation by recombinant human tissue factorJournal of Veterinary Emergency and Critical Care, 2009
- Measurement of prothrombin time (PT) and activated partial thromboplastin time (APTT) on canine citrated plasma samples following different storage conditionsResearch in Veterinary Science, 2008
- Thromboelastographic Tracings in Retired Racing Greyhounds and in Non-Greyhound DogsJournal of Veterinary Internal Medicine, 2008
- Thromboelastographic Evaluation of Hemostatic Function in Dogs with Disseminated Intravascular CoagulationJournal of Veterinary Internal Medicine, 2008
- Anti—factor Xa Assay: An Effective Method to Determine the Appropriate Dose of Heparin in Pregnant WomenClinical and Applied Thrombosis/Hemostasis, 2008
- Anticoagulant Effects of Low-Molecular-Weight Heparins in Healthy CatsJournal of Veterinary Internal Medicine, 2007
- Effects of Clopidogrel on the Rebound Hypercoagulable State After Heparin Discontinuation in Patients With Acute Coronary SyndromesJACC, 2005
- Pharmacokinetics and pharmacodynamics of a therapeutic dose of unfractionated heparin (200 U/kg) administered subcutaneously or intravenously to healthy dogsVeterinary Clinical Pathology, 2005
- Thromboelastography: a tool for measuring hypercoagulability, hypocoagulability, and fibrinolysisJournal of Veterinary Emergency and Critical Care, 2005
- The monitoring of heparin administration by screening tests in experimental dogsResearch in Veterinary Science, 2001